drug
TLL-018
Phase 2updated 3mo agoby Hangzhou Highlightll Pharmaceutical Co Ltd
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying TLL-018
- phase3A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis
- phase3A Study of Efficacy and Safety of TLL-018 in CSU Participants
- phase1Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects
- phase3A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs
- phase2The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that